Treating type 2 diabetes mellitus: A growing epidemic

被引：8

作者：

Weinstock, RS

机构：

[1] SUNY Upstate Med Univ, Div Endocrinol Diabet & Metab, Syracuse, NY 13210 USA

[2] Dept Vet Affairs Med Ctr, Syracuse, NY USA

来源：

MAYO CLINIC PROCEEDINGS | 2003年 / 78卷 / 04期

关键词：

D O I：

10.4065/78.4.411

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：411 / 413

页数：3

共 31 条

[1]

*AM COLL END, 2002, ENDOCR PRACT S1, V8, P5

[2] Projection of diabetes burden through 2050 - Impact of changing demography and disease prevalence in the US [J].

Boyle, JP ;

Honeycutt, AA ;

Narayan, KMV ;

Hoerger, TJ ;

Geiss, LS ;

Chen, H ;

Thompson, TJ .

DIABETES CARE, 2001, 24 (11) :1936-1940

[3] Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women [J].

Buchanan, TA ;

Xiang, AH ;

Peters, RK ;

Kjos, SL ;

Marroquin, A ;

Goico, J ;

Ochoa, C ;

Tan, S ;

Berkowitz, K ;

Hodis, HN ;

Azen, SP .

DIABETES, 2002, 51 (09) :2796-2803

[4] Pharmacological management of type 2 diabetes mellitus: Rationale for rational use of insulin [J].

Chan, JL ;

Abrahamson, MJ .

MAYO CLINIC PROCEEDINGS, 2003, 78 (04) :459-467

[5] Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].

Chiasson, JL ;

Josse, RG ;

Gomis, R ;

Hanefeld, M ;

Karasik, A ;

Laakso, M .

LANCET, 2002, 359 (9323) :2072-2077

[6]

Clark N, 2003, DIABETES CARE, V26, P3333

[7]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[8]

*DIAB PREV PROGR R, 2002, NEW ENGL J MED, V346, P393, DOI [DOI 10.1056/NEJMOA012512, 10.1056/NEJMoa012512]

[9]

Freeman DJ, 2001, CIRCULATION, V103, P357

[10] Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes [J].

Gaede, P ;

Vedel, P ;

Larsen, N ;

Jensen, GVH ;

Parving, H ;

Pedersen, O .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) :383-393

← 1 2 3 4 →